Glob Bioenergi Cash Flow Conversion Efficiency

Latest as of December 2024: -3.463x

Glob Bioenergi cash flow conversion efficiency. Based on the latest financial reports, Glob Bioenergi (ALGBE) has a cash flow conversion efficiency ratio of -3.463x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-5.86 Million ≈ $-6.85 Million USD) by net assets (€1.69 Million ≈ $1.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Glob Bioenergi for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Glob Bioenergi (2008–2024)

Cash flow conversion efficiency of Glob Bioenergi from 2008 to 2024. This chart illustrates how Glob Bioenergi's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Glob Bioenergi for real-time trading data and today's change.

Glob Bioenergi Cash Flow Conversion Ratio Explained

Glob Bioenergi cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Glob Bioenergi Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Glob Bioenergi ranked by their cash flow conversion efficiency. Review ALGBE FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
PBT Group Ltd JSE:PBG	0.295x
China Liberal Education Holdings NASDAQ:CLEU	-0.015x
Lyra Therapeutics Inc NASDAQ:LYRA	0.566x
RM Infrastructure Income PLC LSE:RMII	-0.021x
LeddarTech Holdings Inc NASDAQ:LDTC	0.084x
Southstone Minerals Ltd V:SML	-0.898x
Tortilla Mexican Grill PLC LSE:MEX	-0.810x
PUNCH PUNK S.A. ZY-10 F:6K7	N/A

Annual Cash Flow Conversion Efficiency for Glob Bioenergi (2008–2024)

The table below shows the annual cash flow conversion efficiency of Glob Bioenergi from 2008 to 2024. Also see Glob Bioenergi total assets for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€1.69 Million ≈ $1.98 Million	€-7.51 Million ≈ $-8.77 Million	-4.435x	-484.55%
2023-12-31	€10.41 Million ≈ $12.17 Million	€-7.90 Million ≈ $-9.23 Million	-0.759x	+42.83%
2022-12-31	€7.65 Million ≈ $8.94 Million	€-10.15 Million ≈ $-11.87 Million	-1.327x	-108.53%
2021-12-31	€18.66 Million ≈ $21.82 Million	€-11.88 Million ≈ $-13.88 Million	-0.636x	+75.39%
2020-12-31	€4.13 Million ≈ $4.83 Million	€-10.68 Million ≈ $-12.49 Million	-2.585x	-144.39%
2019-12-31	€9.71 Million ≈ $11.35 Million	€-10.27 Million ≈ $-12.01 Million	-1.058x	+10.43%
2018-12-31	€6.28 Million ≈ $7.34 Million	€-7.42 Million ≈ $-8.67 Million	-1.181x	-78.73%
2017-12-31	€13.72 Million ≈ $16.04 Million	€-9.07 Million ≈ $-10.60 Million	-0.661x	+33.80%
2016-12-31	€9.30 Million ≈ $10.87 Million	€-9.28 Million ≈ $-10.85 Million	-0.998x	+10.80%
2015-12-31	€7.90 Million ≈ $9.23 Million	€-8.84 Million ≈ $-10.33 Million	-1.119x	-176.09%
2014-12-31	€17.88 Million ≈ $20.91 Million	€-7.25 Million ≈ $-8.47 Million	-0.405x	-111.88%
2013-12-31	€23.77 Million ≈ $27.79 Million	€-4.55 Million ≈ $-5.32 Million	-0.191x	-70.32%
2012-12-31	€6.47 Million ≈ $7.57 Million	€-727.00K ≈ $-849.94K	-0.112x	+84.97%
2011-12-31	€3.95 Million ≈ $4.62 Million	€-2.95 Million ≈ $-3.45 Million	-0.747x	-98.98%
2010-12-31	€6.05 Million ≈ $7.08 Million	€-2.27 Million ≈ $-2.66 Million	-0.376x	-110.78%
2009-12-31	€-296.00K ≈ $-346.06K	€-1.03 Million ≈ $-1.21 Million	3.483x	+584.33%
2008-12-31	€396.30K ≈ $463.31K	€-285.00K ≈ $-333.19K	-0.719x	--

About Glob Bioenergi

PA:ALGBE France Specialty Chemicals

Market Cap

$392.09K

€335.38K EUR

Market Cap Rank

#31219 Global

#587 in France

Share Price

€0.02

Change (1 day)

+0.00%

52-Week Range

€0.02 - €0.02

All Time High

€35.93